Correlation Between Pmv Pharmaceuticals and Acrivon Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Acrivon Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Acrivon Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pmv Pharmaceuticals and Acrivon Therapeutics, Common, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Acrivon Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Acrivon Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Acrivon Therapeutics,.
Diversification Opportunities for Pmv Pharmaceuticals and Acrivon Therapeutics,
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Pmv and Acrivon is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Acrivon Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acrivon Therapeutics, and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Acrivon Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acrivon Therapeutics, has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Acrivon Therapeutics, go up and down completely randomly.
Pair Corralation between Pmv Pharmaceuticals and Acrivon Therapeutics,
Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to generate 0.33 times more return on investment than Acrivon Therapeutics,. However, Pmv Pharmaceuticals is 3.05 times less risky than Acrivon Therapeutics,. It trades about -0.21 of its potential returns per unit of risk. Acrivon Therapeutics, Common is currently generating about -0.09 per unit of risk. If you would invest 150.00 in Pmv Pharmaceuticals on October 20, 2024 and sell it today you would lose (13.00) from holding Pmv Pharmaceuticals or give up 8.67% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pmv Pharmaceuticals vs. Acrivon Therapeutics, Common
Performance |
| Timeline |
| Pmv Pharmaceuticals |
| Acrivon Therapeutics, |
Pmv Pharmaceuticals and Acrivon Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pmv Pharmaceuticals and Acrivon Therapeutics,
The main advantage of trading using opposite Pmv Pharmaceuticals and Acrivon Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Acrivon Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acrivon Therapeutics, will offset losses from the drop in Acrivon Therapeutics,'s long position.| Pmv Pharmaceuticals vs. MediciNova | Pmv Pharmaceuticals vs. Pharvaris BV | Pmv Pharmaceuticals vs. PepGen | Pmv Pharmaceuticals vs. Anebulo Pharmaceuticals |
| Acrivon Therapeutics, vs. Aerovate Therapeutics | Acrivon Therapeutics, vs. Adagene | Acrivon Therapeutics, vs. Rezolute | Acrivon Therapeutics, vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |